| scholarly article | Q13442814 |
| P50 | author | Marc E Lippman | Q91264999 |
| P2093 | author name string | Huff K | |
| Bolan G | |||
| P4510 | describes a project that uses | MCF-7 | Q1881253 |
| MDA-MB-231 | Q17577870 | ||
| Evsa-E | Q54832984 | ||
| Evsa-T | Q54832986 | ||
| G-11 | Q54835338 | ||
| HBT-39b | Q54881459 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | breast cancer | Q128581 |
| estrogen | Q277954 | ||
| cell line | Q21014462 | ||
| P304 | page(s) | 4595-4601 | |
| P577 | publication date | 1976-12-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture | |
| P478 | volume | 36 |
| Q37405432 | 17 beta-estradiol regulates and v-Ha-ras transfection constitutively enhances MCF7 breast cancer cell interactions with basement membrane |
| Q41366482 | 8th San Antonio Breast Cancer Symposium--Plenary lecture. Autocrine and paracrine growth regulation of human breast cancer |
| Q54438676 | A new triphenylethylene compound, Fc-1157a. II. Antitumor effects. |
| Q67243490 | A phase II trial of tamoxifen, premarin, methotrexate and 5-fluorouracil in metastatic breast cancer |
| Q68674574 | A study on the correlation between estrogen receptor, progesterone receptor and tamoxifen binding sites in human breast cancer tissues |
| Q92266014 | A triphenylethylene nonsteroidal SERM attenuates cervical cancer growth |
| Q37105231 | A twenty-first century cancer epidemic caused by obesity: the involvement of insulin, diabetes, and insulin-like growth factors |
| Q36201094 | Absence of fibronectin and presence of plasminogen activator in both normal and malignant human mammary epithelial cells in culture |
| Q37572804 | Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. |
| Q45064398 | Alteration of steroid hormone sensitivity during the cultivation of human mammary carcinoma cells |
| Q28344327 | Alterations in the insulin-like growth factor system during treatment with diethylstilboestrol in patients with metastatic breast cancer |
| Q33919419 | Amplification by host cell factors of a sequence contained within the herpes simplex virus 1 genome |
| Q42515445 | Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line |
| Q43505469 | Anti-proliferative effects of 1,2-diphenylethane oestrogens and anti-oestrogens on human breast cancer cells |
| Q43685275 | Antiestrogen action in breast cancer cells: modulation of proliferation and protein synthesis, and interaction with estrogen receptors and additional antiestrogen binding sites |
| Q41501630 | Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells |
| Q34661852 | Aromatase inhibitors and inactivators for breast cancer therapy |
| Q41717390 | Assembly of amino-terminally deleted desmin in vimentin-free cells |
| Q69651867 | Autoradiographic localization of [3H]hydroxytamoxifen to uterine oestrogen- and antioestrogen-binding sites |
| Q42660326 | Biological differences among MCF-7 human breast cancer cell lines from different laboratories |
| Q38291756 | Biphasic actions of estrogen on colon cancer cell growth: possible mediation by high- and low-affinity estrogen binding sites |
| Q41246970 | Cell cycle expression of estrogen receptors determined by image analysis on human breast cancer cells in vitro and in vivo |
| Q67926542 | Cell cycle synchronization induced by tamoxifen and 17 beta-estradiol on MCF-7 cells using flow cytometry and a monoclonal antibody against bromodeoxyuridine |
| Q36089380 | Cloning of cDNA sequences of a progestin-regulated mRNA from MCF7 human breast cancer cells |
| Q44904491 | Control of proliferation of MCF-7 breast cancer cells in a commercial preparation of charcoal-stripped adult bovine serum |
| Q52831840 | Development of a new human breast cancer cell line Ia-270. |
| Q61971557 | Dexamethasone modulation of in vitro growth pattern and of lung colonization ability in clones of a metastatic BALB/c mammary carcinoma cell line |
| Q68585705 | Down-regulation of androgen receptor by progestins and interference with estrogenic or androgenic stimulation of mammary carcinoma cell growth |
| Q36047792 | Effect of 17 beta-oestradiol on growth curves and flow cytometric DNA distribution of two human breast carcinomas grown in nude mice |
| Q54362151 | Effect of continuous vs intermittent application of 3-OH-tamoxifen or tamoxifen on the proliferation of the human breast cancer cell line MCF-7 M1. |
| Q36080069 | Effects of 4-hydroxytamoxifen and a novel pure antioestrogen (ICI 182780) on the clonogenic growth of human breast cancer cells in vitro. |
| Q68144866 | Effects of tamoxifen and 4-hydroxytamoxifen on synchronized cultures of the human breast cancer cell line MCF-7 |
| Q45082362 | Effects of tamoxifen on growth and apoptosis of estrogen-dependent and -independent human breast cancer cells |
| Q41585013 | Effects of tamoxifen on human breast cancer cells in vitro |
| Q40157275 | Efforts to combine endocrine and chemotherapy in the management of breast cancer: Do two and two equal three? |
| Q37040395 | Endocrine Consequences of Continuous Antiestrogen Therapy with Tamoxifen in Premenopausal Women |
| Q39558942 | Endocrine Response Phenotypes Are Altered by Charcoal-Stripped Serum Variability. |
| Q34095945 | Endocrine Treatment - 'Old-Fashioned' Therapy Becoming Redundant in an Era of Molecular Medicine? |
| Q42495085 | Endocrine effects of combined somatostatin analog and bromocriptine therapy in women with advanced breast cancer |
| Q35857999 | Endocrine organ metastases from breast carcinoma |
| Q36386322 | Endocrine resistance in breast cancer--An overview and update |
| Q39698594 | Endocrine therapy of human breast cancer grown in nude mice |
| Q36359057 | Enrichment of estradiol-receptor complexes in a transcriptionally active fraction of chromatin from MCF-7 cells |
| Q71125622 | Estradiol stimulates synthesis of a major intracellular protein in a human breast cancer cell line (MCF-7) |
| Q37592386 | Estrogen induction of growth factors specific for hormone-responsive mammary, pituitary, and kidney tumor cells |
| Q54393577 | Estrogen inhibits the growth of MCF-7 cell variants resistant to transforming growth factor-beta. |
| Q40847961 | Estrogen mitogenic action. III. is phenol red a "red herring"? |
| Q73096702 | Estrogen mitogenic action. ii. negative regulation of the steroid hormone-responsive growth of cell lines derived from human and rodent target tissue tumors and conceptual implications |
| Q35991945 | Estrogen suppresses melatonin-enhanced hyperactivation of hamster spermatozoa |
| Q36054746 | Estrogens and growth factors induce the mRNA of the 52K-pro-cathepsin-D secreted by breast cancer cells |
| Q33619562 | Estrogens increase the expression of fibulin-1, an extracellular matrix protein secreted by human ovarian cancer cells |
| Q33308716 | Functional ablation of pRb activates Cdk2 and causes antiestrogen resistance in human breast cancer cells |
| Q24564158 | Genomic organization of the human oestrogen receptor gene |
| Q41654286 | Growth factor involvement in the multihormonal regulation of MCF-7 breast cancer cell growth in soft agar |
| Q36686536 | Growth factor, steroid, and steroid antagonist regulation of cyclin gene expression associated with changes in T-47D human breast cancer cell cycle progression |
| Q42271266 | Growth regulation of two rat adenocarcinoma cell lines by dexamethasone and progesterone |
| Q36619905 | High level expression of differentially localized BAG-1 isoforms in some oestrogen receptor-positive human breast cancers. |
| Q45106547 | Histone acetylation decreased by estradiol in the MCF-7 human mammary cancer cell line |
| Q66926245 | Hormone sensitivity of gynecological tumor cells in tissue culture |
| Q41628377 | Identification of estrogen-inducible growth factors (estromedins) for rat and human mammary tumor cells in culture |
| Q35871070 | In vitro effect of oestradiol on thymidine uptake in pulmonary vascular smooth muscle cell: role of the endothelium |
| Q36027345 | Indirect mechanism of oestradiol stimulation of cell proliferation of human breast cancer cell lines |
| Q52725035 | Influence of estradiol on the total uptake and incorporation of thymidine in human breast cancer (MCF-7) in long-term cell culture. Comparison of autoradiographic and biochemical methods. |
| Q68061049 | Inhibition of postconfluent focus production in cultures of MCF-7 human breast cancer cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin |
| Q35978350 | Initial radiation-induced DNA damage in human tumour cell lines: a correlation with intrinsic cellular radiosensitivity. |
| Q70333902 | Integration of Hormonal Agents and Chemotherapy for the Treatment of Women With Advanced Breast Cancer |
| Q33754852 | Integrative analyses of gene expression and DNA methylation profiles in breast cancer cell line models of tamoxifen-resistance indicate a potential role of cells with stem-like properties |
| Q42798186 | Interrelationship between estradiol and tamoxifen responses for clinical breast carcinoma cells cultured on contact-sensitive plates |
| Q36138978 | Irreversible loss of the oestrogen receptor in T47D breast cancer cells following prolonged oestrogen deprivation |
| Q33993658 | Is there a growing role for endocrine therapy in the treatment of breast cancer? |
| Q24815103 | Large effects from small exposures. I. Mechanisms for endocrine-disrupting chemicals with estrogenic activity |
| Q36275032 | Low Dose, Low Cost Estradiol Pellets Can Support MCF-7 Tumour Growth in Nude Mice without Bladder Symptoms. |
| Q67357696 | Mechanisms of action of estrogens physiological and pharmacological aspects of hormonal "receptivity". The anti-estrogens (author's transl) |
| Q71100431 | Mechanisms of estrogen and antiestrogen action in mammary cancer |
| Q41583637 | Medroxyprogesterone acetate inhibits the proliferation of estrogen- and progesterone-receptor negative MFM-223 human mammary cancer cells via the androgen receptor |
| Q89263231 | Metabolites of n-Butylparaben and iso-Butylparaben Exhibit Estrogenic Properties in MCF-7 and T47D Human Breast Cancer Cell Lines |
| Q40105171 | Metabolites of tamoxifen in animals and man: Identification, pharmacology, and significance |
| Q36370545 | MiR-214 increases the sensitivity of breast cancer cells to tamoxifen and fulvestrant through inhibition of autophagy |
| Q64064359 | MicroRNAs as possible indicators of drug sensitivity in breast cancer cell lines |
| Q36987868 | Mitogenic regulation of normal and malignant breast epithelium |
| Q36517144 | Models and Mechanisms of Acquired Antihormone Resistance in Breast Cancer: Significant Clinical Progress Despite Limitations |
| Q41817542 | Modulation of the proliferative response of breast cancer cells to growth factors by oestrogen |
| Q70565921 | Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-based in vitro assays |
| Q37751530 | Molecular basis for therapy resistance |
| Q55452150 | Multiple Routes to Oestrogen Antagonism. |
| Q41650732 | New cell lines of human breast cancer origin |
| Q37401534 | Nuclear receptor co-activators and HER-2/neu are upregulated in breast cancer patients during neo-adjuvant treatment with aromatase inhibitors |
| Q36670973 | Oestradiol enhances tumour regression induced by B7-1/IL-2 adenoviral gene transfer in a murine model of breast cancer |
| Q67402785 | Oestrogen binding proteins in bone cell cytosol |
| Q35991956 | Oestrogen receptor status and the response of human breast cancer cell lines to a combination of methotrexate and 17-beta oestradiol. |
| Q36467744 | Oestrogenic activity of tamoxifen and its metabolites on gene regulation and cell proliferation in MCF-7 breast cancer cells |
| Q67578189 | Optimization of estrogen growth response in MCF-7 cells |
| Q40607026 | Perinatal factors increase breast cancer risk. |
| Q24631017 | Phenol red in tissue culture media is a weak estrogen: implications concerning the study of estrogen-responsive cells in culture |
| Q36215906 | Phosphorylation, glycosylation, and proteolytic activity of the 52-kD estrogen-induced protein secreted by MCF7 cells |
| Q37612930 | Physicochemical and genetic evidence for specific antiestrogen binding sites |
| Q40833725 | Physiologic effects of steroid hormones and postmenopausal hormone replacement on the female breast and breast cancer risk |
| Q35996338 | Placental Kisspeptins Differentially Modulate Vital Parameters of Estrogen Receptor-Positive and -Negative Breast Cancer Cells |
| Q33847525 | Potential of l-buthionine sulfoximine to enhance the apoptotic action of estradiol to reverse acquired antihormonal resistance in metastatic breast cancer |
| Q35982067 | Prolactin receptor does not correlate with oestrogen and progesterone receptors in primary breast cancer and lacks prognostic significance. Ten year results of the Naples adjuvant (GUN) study |
| Q67789526 | Proliferative inhibition of human breast carcinoma cells by high concentration estradiol does not alter radiosensitivity |
| Q40661647 | Psychosocial factors in the development and progression of breast cancer. |
| Q35817167 | Quercetin Suppresses Twist to Induce Apoptosis in MCF-7 Breast Cancer Cells |
| Q42229012 | Reduction of equilibrative nitrobenzylthioinosine-sensitive nucleoside transporter in tamoxifen-treated MCF-7 cells: an oestrogen-reversible phenomenon |
| Q39991527 | Relationship between p53 status and radiosensitivity in human tumour cell lines. |
| Q24545440 | Relative binding affinity-serum modified access (RBA-SMA) assay predicts the relative in vivo bioactivity of the xenoestrogens bisphenol A and octylphenol |
| Q35597370 | Restoration of normal morphology and estrogen responsiveness in cultured vaginal and uterine epithelia transplanted with stroma |
| Q34084267 | SETD6 controls the expression of estrogen-responsive genes and proliferation of breast carcinoma cells |
| Q55437428 | Sex differences influence intestinal epithelial stem cell proliferation independent of obesity. |
| Q47673626 | Sleep and circadian disruption and incident breast cancer risk: An evidence-based and theoretical review |
| Q33845920 | Specific estrogen-induced cell proliferation of cultured Syrian hamster renal proximal tubular cells in serum-free chemically defined media |
| Q71100440 | Specific protein synthesis regulated by estrogen in human breast cancer |
| Q35747835 | Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin |
| Q68532635 | Stimulation of breast cancer cells in vitro by the environmental estrogen enterolactone and the phytoestrogen equol |
| Q54394361 | Stimulatory effects of androgen and antiandrogen on the in vitro proliferation of human mammary carcinoma cells. |
| Q36364111 | Sustained growth in primary culture of normal mammary epithelial cells embedded in collagen gels |
| Q36883778 | Synthesis of novel estrogen receptor antagonists using metal-catalyzed coupling reactions and characterization of their biological activity |
| Q70158373 | Tamoxifen binding sites in human mammary cancers |
| Q39740131 | Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer |
| Q80089159 | Targeted functional imaging in breast cancer |
| Q33561391 | The 5' flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein |
| Q36880048 | The Metabolism, Analysis, and Targeting of Steroid Hormones in Breast and Prostate Cancer |
| Q27026813 | The association between type 2 diabetes mellitus and women cancer: the epidemiological evidences and putative mechanisms |
| Q33856027 | The estrogen receptor: a logical target for the prevention of breast cancer with antiestrogens |
| Q72919563 | The influence of a novel cyclopropyl antiestrogen (compound 7a) on human breast cancer cells in culture |
| Q70108140 | The management of nonmetastatic locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery |
| Q33827011 | The mechanistic target for rapamycin pathway is related to the phosphorylation score for estrogen receptor-α in human breast tumors in vivo |
| Q36292824 | The oestrogen-like effect of 4-hydroxytamoxifen on induction of transforming growth factor alpha mRNA in MDA-MB-231 breast cancer cells stably expressing the oestrogen receptor |
| Q33928180 | Transient expression of the chicken lysozyme gene after transfer into human cells |
| Q42823206 | Two new estrogen-supersensitive variants of the MCF-7 human breast cancer cell line |
| Q40644013 | What do we know and what don't we know about tamoxifen in the human uterus |
| Q40790197 | William L. McGuire Memorial Symposium. Control of breast cancer cell growth by steroids and growth factors: interactions and mechanisms |
| Q66851232 | Wilms' tumor cell line |
| Q36958376 | YAP/TAZ regulates the insulin signaling via IRS1/2 in endometrial cancer |
Search more.